This is how Dr. Henry Miller (of the Hoover Institution) describes the fat-substitute Olestra, in an article written for the Cato Institute’s magazine, Regulation. Despite the product’s repeatedly demonstrated safety and usefulness, it continues to get a thumbs-down rating from über-nanny Michael Jacobson at the Center for Science in the Public Interest. Perhaps CSPI’s opposition to this revolutionary product was influenced by the $40,000 in grants it accepted during 1998 and 1999 from the Helena Rubenstein Foundation for “public education on [the] health effects of olestra.” Whatever CSPI’s reasons, Dr. Miller has the scoop on why the group is dead wrong. For the latest issue of Regulation in its entirety, click here.